Total Funding
64
54
Total FundingSeries B raised
Growth Score 64 in past quarter
-5 pts
Heat Score 54 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
45990
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
Robin Smith: Chief Executive OfficerPast Role: Seaport Diagnostics, Founder and CEO- Teresa Abraham: VP, Scientific and Technical Affairs
About the Company
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches. The company possesses a portfolio of capabilities and technologies encompassing innovative sample collection, next-generation diagnostics, computational biology, and printed electronics. These elements
contribute to the global accessibility of crucial diagnostic results for consumers.
